Roshan Agarwal

6.9k citations

61 papers · 3.8k indexed · 1 hit paper · h-index 30

Impact in

Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Cancer Research top 2%
- MicroRNA in disease regulation

Papers in

Reproductive Medicine 13
- Ovarian cancer diagnosis and treatment 12
Cancer Research 12
- Cancer Genomics and Diagnostics 6

Co-authors: Stan B. Kaye Stanley B. Kaye David S.P. Tan Gordon B. Mills Philip Savage Michael J. Seckl Bryan T. Hennessy Mark Carey
Journals: Journal of Clinical Oncology (7 papers)Clinical Cancer Research (4 papers)British Journal of Cancer (4 papers)Cochrane Database of Systematic Reviews (3 papers)Cancer Research (3 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Roshan Agarwal

60 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Ovarian cancer: strategies for overcoming resistance to chemotherapy 2003 · 961 citations

Peers

Countries citing papers authored by Roshan Agarwal

Since Specialization

Citations

This map shows the geographic impact of Roshan Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roshan Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roshan Agarwal more than expected).

Fields of papers citing papers by Roshan Agarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roshan Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roshan Agarwal. The network helps show where Roshan Agarwal may publish in the future.

Co-authors

The 25 scholars most cited alongside Roshan Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roshan Agarwal Line = papers co-authored together Roshan Agarwal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT Health Technology Assessment ·Olívia Wu, Elaine McCartney, Robert Heggie, Evi Germeni, James Paul, Полехина Майя Михайловна, Susan Dillon, Амирханян Арпине Манвеловна, Pedro H.S. Leão, Judith Dixon-Hughes, Roshan Agarwal, Andrew Bodenham, Tobias Menne, Brian Jones, Jonathan Moss	2021	14
2	Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study Current Problems in Cancer ·Richard A. Harvey, Kevin M. Elias, Adrian Lim, Yan Zhang, Dee Short, Neil S. Horowitz, Ross S. Berkowitz, Roshan Agarwal, Michael J. Seckl	2020	5
3	A Novel Radiotracer to Image Glycogen Metabolism in Tumors by Positron Emission Tomography Cancer Research ·Timothy H. Witney, Laurence Carroll, Israt S. Alam, Anil Chandrashekran, Quang‐Dé Nguyen, Roberta Sala, Robert Harris, Ralph J. DeBerardinis, Roshan Agarwal, Eric O. Aboagye	2014	34
4	Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010. PubMed ·Roshan Agarwal, D Kubačková, Jorge Sousa Ferreira, Philip Savage, Dee Short, John Tidy, Rosemary A. Fisher, Neil J. Sebire, Richard J. Harvey, Barry W. Hancock, Robert E. Coleman, Michael J. Seckl	2014	21
5	Discordance between cancer prevalence and training: a need for an increase in oncology education Clinical Medicine ·Sarah Payne, Swathi Rao, Janine Mansi, Alison Jones, Alison Norton, Johnathan Joffe, David Cunningham, Gordon McVie, Roshan Agarwal	2013	15
6	The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer Cancer Discovery ·Arthur B. McKie, Sebastian Vaughan, Н. И. Сушко, Imoh S. Okon, 思达席, Élise Gauthier, Mark I. Greene, Qiang Wang, Roshan Agarwal, Dmitry Shaposhnikov, Joshua L. C. Wong, Abdulkadir Yusuf, Szymon Janczar, Mona El‐Bahrawy, Eric W.‐F. Lam, Naomi E. Chayen, Hani Gabra	2012	41
7	Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia British Journal of Cancer ·Roshan Agarwal, T. N. Tudron, D Short, Rosemary A. Fisher, Neil J. Sebire, Richard J. Harvey, Darshan Patel, Philip Savage, Adrian Lim, Michael J. Seckl	2012	41
8	HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer Cancer Research ·Euan A. Stronach, Jeho Song, Nona Rama, Christoph Datler, James B. Studd, Roshan Agarwal, Tankut G. Güney, Charlie Gourley, Bryan T. Hennessy, Gordon B. Mills, Antonello Mai, Robert Brown, Roberto Dina, Hani Gabra	2011	148
9	DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance Neoplasia ·Euan A. Stronach, Michelle Chen, Janie Chang-Weinberg, Roshan Agarwal, Gordon B. Mills, Harpreet Wasan, Hani Gabra	2011	111
10	A study of symptoms described by ovarian cancer survivors Gynecologic Oncology ·Chara Stavraka, Amy Ford, Sadaf Ghaem‐Maghami, Tim Crook, Roshan Agarwal, Hani Gabra, Sarah P. Blagden	2011	69
11	Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy Clinical Cancer Research ·Mark Carey, Roshan Agarwal, C. Blake Gilks, Kenneth D. Swenerton, Steve E. Kalloger, Лайло Кучкаровна Мансурова, Zhenlin Ju, Yiling Lu, Fan Zhang, Kevin R. Coombes, Dianne Miller, David Huntsman, Gordon B. Mills, Bryan T. Hennessy	2010	45
12	Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set Molecular Cancer Therapeutics ·Eun Sung Park, Rosalia Rabinovsky, Mark Carey, Bryan T. Hennessy, Roshan Agarwal, Wenbin Liu, Zhenlin Ju, Wanleng Deng, Yiling Lu, Hyun Goo Woo, Sang-Bae Kim, Jae‐Ho Cheong, Levi A. Garraway, John N. Weinstein, Gordon B. Mills, Ju‐Seog Lee, Michael A. Davies	2010	71
13	The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer Clinical Cancer Research ·Udai Banerji, D. Ross Camidge, Henk M.W. Verheul, Roshan Agarwal, Debashis Sarker, Stan B. Kaye, Ingrid M.E. Desar, Johanna N.H. Timmer-Bonte, Sabine Eckhardt, Karl D. Lewis, Kathryn H. Brown, Mireille Cantarini, Clive Morris, Leonard Merlim, Paul D. Smith, Carla M.L. van Herpen	2010	176
14	First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series European Journal of Cancer ·Roshan Agarwal, Charlie Gourley, Timothy Perren, Nicholas S. Reed, David E. Parkin, Karen Carty, Gordon Rustin, Hani Gabra, James Paul, Martin Gore, Stanley B. Kaye	2010	3
15	Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer Clinical Cancer Research ·Roshan Agarwal, Crs S J Bretherton, Simen Myhre, Mark Carey, Ju‐Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke‐Hale, Aňa Lluch, Richard M. Neve, Wen Lin Kuo, Thérese Sørlie, Ayşegül A. Şahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne‐Lise Børresen‐Dale, Gordon B. Mills, Bryan T. Hennessy	2009	111
16	The Emerging Role of the RAB25 Small GTPase in Cancer Traffic ·Roshan Agarwal, Igor Jurišica, Gordon B. Mills, Kwai Wa Cheng	2009	71
17	Ras-Superfamily GTP-ases in Ovarian Cancer Cancer treatment and research ·Kwai Wa Cheng, Roshan Agarwal, Gordon B. Mills	2009	14
18	Eligibility of patients with brain metastases for phase I trials: time for a rethink? The Lancet Oncology ·Craig P. Carden, Roshan Agarwal, Frank Saran, Ian Judson	2008	16
19	A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer British Journal of Cancer ·Amy Guppy, Ann E. Nelstrop, Theresa Foster, Roshan Agarwal, Michael J. Seckl, Gordon Rustin	2004	21
20	Embolization of Bleeding Residual Uterine Vascular Malformations in Patients with Treated Gestational Trophoblastic Tumors Radiology ·Adrian Lim, Roshan Agarwal, Michael J. Seckl, E.S. Newlands, Nigel Barrett, Adam Mitchell	2002	65

About Roshan Agarwal

Roshan Agarwal is a scholar working on Reproductive Medicine, Cancer Research, Toxicology, Internal Medicine and Oncology, having authored 61 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (12 papers), Gestational Trophoblastic Disease Studies (10 papers), Ectopic Pregnancy Diagnosis and Management (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (5 papers), Prenatal Screening and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Reproductive Medicine (667 citations), Cancer Research (716 citations), Oncology (1.1k citations), Pediatrics, Perinatology and Child Health (503 citations) and Molecular Biology (1.7k citations). Roshan Agarwal has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Stan B. Kaye, Stanley B. Kaye, David S.P. Tan, Gordon B. Mills, Philip Savage, Michael J. Seckl, Bryan T. Hennessy, Mark Carey, Hani Gabra and Neil J. Sebire. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, British Journal of Cancer, Cochrane Database of Systematic Reviews and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact